Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa

Motasim Badri; Gary Maartens; Sundhiya Mandalia; Linda-Gail Bekker; John R Penrod; Robert W Platt; Robin Wood; Eduard J Beck

doi:10.1371/journal.pmed.0030004

Back

Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa

Journal article

Open access

Peer reviewed

Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa

Motasim Badri, Gary Maartens, Sundhiya Mandalia, Linda-Gail Bekker, John R Penrod, Robert W Platt, Robin Wood and Eduard J Beck

PLoS medicine, Vol.3(1), pp.48-56

01/01/2006

DOI: https://doi.org/10.1371/journal.pmed.0030004

PMID: 16318413

Abstract

AIDS

Chronic Disease Management

Epidemiology

Health Economics

Health Policy

HIV

HIV Infection

Infectious Diseases

Medicine in Developing Countries

Public Health

Resource allocation and rationing

Sexual Health

Healthcare costs for HIV-infected South African adults on HAART compared with costs for HIV-infected controls not on HAART. Authors conclude HAART is cost effective.

Files and links (1)

url

https://doi.org/10.1371/journal.pmed.0030004View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa
Creators - without role: Motasim Badri - Desmond Tutu HIV Foundation
Gary Maartens - University of Cape Town
Sundhiya Mandalia - Chelsea and Westminster Hospital
Linda-Gail Bekker - Desmond Tutu HIV Foundation
John R Penrod - McGill University Health Centre
Robert W Platt - McGill University
Robin Wood - Desmond Tutu HIV Foundation
Eduard J Beck - Chelsea and Westminster Hospital
Publication Details: PLoS medicine, Vol.3(1), pp.48-56
Publisher: Public Library of Science
Identifiers: 9921007508331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article